| HOME >> MEDICINE >> TECHNOLOGY |
Markets for cardiovascular devices 153
Marketing of innovative cardiovascular drug delivery devices 153
Direct to consumer advertising of DES 154
Future trends in the integration of drug delivery with therapeutics 154
Future prospects of cardiovascular drug delivery 154
7. Companies involved in Cardiovascular Drug Delivery 155
Profiles of companies 155
Collaborations 241
8. References 245
List of Tables
Table 1 1: Landmarks in the historical evolution of cardiovascular drug delivery 13
Table 1 2: Gene polymorphisms that alter cardiovascular response to drugs 18
Table 2 1: Routes of drug delivery used for treatment of cardiovascular disorders 25
Table 2 2: Formulations for drug delivery to the cardiovascular system 27
Table 2 3: Improved methods of systemic drug delivery of cardiovascular drugs 32
Table 2 4: Targeted delivery of therapeutic substances to the cardiovascular system 35
Table 2 5: Classification of devices for drug delivery to the cardiovascular system 36
Table 2 6: Various methods of delivery of therapeutic agents for hypertension 41
Table 2 7: Marketed controlled/ extended release preparation for hypertension 43
Table 2 8: Drug delivery in ischemic heart disease 45
Table 2 9: Methods of delivery of nitrate therapy in angina pectoris 49
Table 2 10: Drug delivery for peripheral arterial disorders 54
Table 3 1: Clinical trials of cell therapy in cardiovascular disease 73
Table 4 1: Cardiovascular disorders for which gene therapy is being considered. 79
Table 4 2: Catheter-based systems for vector delivery to the cardiovascular system 80
Table 4 3: Potential applications of antisense in cardiovascular disorders 99
Table 4 4: Companies involved in gene therapy of cardiovascular diseases 104
Table 5 1: Treatment of restenosis 108
Table
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |